A Pharmacokinetic/Pharmacodynamic Study of Oral Bexarotene with Cisplatin and Irinotecan in Extensive Stage Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/044/30/05

Funding

  • Ligand Pharmaceuticals Inc